SEVERAL PHARMACEUTICAL COMPANIES HAVE DEMONSTRATED A PREFERENCE TO OUTSOURCE THEIR PATIENT RECRUITMENT OPERATIONS Clinical trials form an essential part of the overall drug development process, evaluating the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials. For additional details, please visit link https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html